Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Past Issues
    • Accepted Articles
    • Email Alerts
    • RSS
    • Terms of Use
  • About PDA JPST
    • JPST Editors and Editorial Board
    • About/Vision/Mission
    • Paper of the Year
  • Author & Reviewer Resources
    • Author Resources / Submit
    • Reviewer Resources
  • JPST Access and Subscriptions
    • PDA Members
    • Institutional Subscriptions
    • Nonmember Access
  • Support
    • Join PDA
    • Contact
    • Feedback
    • Advertising
    • CiteTrack
  • .
    • Visit PDA
    • PDA Letter
    • Technical Reports
    • news uPDATe
    • Bookstore

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
PDA Journal of Pharmaceutical Science and Technology
  • .
    • Visit PDA
    • PDA Letter
    • Technical Reports
    • news uPDATe
    • Bookstore
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
PDA Journal of Pharmaceutical Science and Technology

Advanced Search

  • Home
  • Content
    • Current Issue
    • Past Issues
    • Accepted Articles
    • Email Alerts
    • RSS
    • Terms of Use
  • About PDA JPST
    • JPST Editors and Editorial Board
    • About/Vision/Mission
    • Paper of the Year
  • Author & Reviewer Resources
    • Author Resources / Submit
    • Reviewer Resources
  • JPST Access and Subscriptions
    • PDA Members
    • Institutional Subscriptions
    • Nonmember Access
  • Support
    • Join PDA
    • Contact
    • Feedback
    • Advertising
    • CiteTrack
  • Follow pda on Twitter
  • Visit PDA on LinkedIn
  • Visit pda on Facebook
Research ArticleTechnology/Application

Risk Assessment Approach to Microbiological Controls of Cell Therapies

Tony Cundell, Scott Drummond, Irving Ford, Dona Reber and Donald Singer; members of the Pharmaceutical Microbiology Expert Discussion Group
PDA Journal of Pharmaceutical Science and Technology March 2020, 74 (2) 229-248; DOI: https://doi.org/10.5731/pdajpst.2019.010546
Tony Cundell
1Microbiological Consulting LLC, Scarsdale, NY;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: tonycundell@gmail.com
Scott Drummond
2Johnson & Johnson Companies, NB, NJ;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Irving Ford
3Celgene Corporation, Summit, NJ;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dona Reber
4Pfizer, Collegeville, PA; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Donald Singer
5New Beginnings Microbiology, Phoenixville, PA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 74 no. 2 229-248
DOI 
https://doi.org/10.5731/pdajpst.2019.010546
PubMed 
31941793

Published By 
Parenteral Drug Association (PDA)
Print ISSN 
1079-7440
Online ISSN 
1948-2124
History 
  • Published online April 9, 2020.

Article Versions

  • previous version (January 15, 2020 - 07:38).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© PDA, Inc. 2020

Author Information

  1. Tony Cundell1,*,
  2. Scott Drummond2,
  3. Irving Ford3,
  4. Dona Reber4 and
  5. Donald Singer5
  6. members of the Pharmaceutical Microbiology Expert Discussion Group
  1. 1Microbiological Consulting LLC, Scarsdale, NY;
  2. 2Johnson & Johnson Companies, NB, NJ;
  3. 3Celgene Corporation, Summit, NJ;
  4. 4Pfizer, Collegeville, PA; and
  5. 5New Beginnings Microbiology, Phoenixville, PA
  1. ↵*Corresponding Author: Microbiological Consulting LLC, Scarsdale, NY. E-mail: tonycundell{at}gmail.com.
View Full Text

Cited By...

  • 3 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Comprehensive Study Identifies a Sensitive, Low-Risk, Closed-System Model for Detection of Fungal Contaminants in Cell and Gene Therapy Products
    Nicole E. Putnam, Anna F. Lau, Kimberly E. Hanson
    Journal of Clinical Microbiology 2021 59 11
  • Differentiation of human pluripotent stem cells into insulin-producing islet-like clusters using nanofiltered cell culture medium
    Julia Thorngren, Svitlana Vasylovska, Jules Blanc, Lulu Wu, Levon Manukyan, Albert Mihranyan, Joey Lau
    Frontiers in Membrane Science and Technology 2024 3
  • Report of a clinical and laboratory management of cell therapy for knee cartilage in the face of mycoplasma contamination
    Alessandro Rozim Zorzi, Eliane Antonioli, Juliana Aparecida Preto de Godoy, Oswaldo Keith Okamoto, Andrea Tiemi Kondo, José Mauro Kutner, Camila Cohen Kaleka, Moisés Cohen, Mario Ferretti
    einstein (São Paulo) 2022 20
PreviousNext
Back to top

In This Issue

PDA Journal of Pharmaceutical Science and Technology: 74 (2)
PDA Journal of Pharmaceutical Science and Technology
Vol. 74, Issue 2
March/April 2020
  • Table of Contents
  • Index by Author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on PDA Journal of Pharmaceutical Science and Technology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Risk Assessment Approach to Microbiological Controls of Cell Therapies
(Your Name) has sent you a message from PDA Journal of Pharmaceutical Science and Technology
(Your Name) thought you would like to see the PDA Journal of Pharmaceutical Science and Technology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
13 + 7 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Risk Assessment Approach to Microbiological Controls of Cell Therapies
Tony Cundell, Scott Drummond, Irving Ford, Dona Reber, Donald Singer
PDA Journal of Pharmaceutical Science and Technology Mar 2020, 74 (2) 229-248; DOI: 10.5731/pdajpst.2019.010546

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Risk Assessment Approach to Microbiological Controls of Cell Therapies
Tony Cundell, Scott Drummond, Irving Ford, Dona Reber, Donald Singer
PDA Journal of Pharmaceutical Science and Technology Mar 2020, 74 (2) 229-248; DOI: 10.5731/pdajpst.2019.010546
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Overview of Contamination Control
    • Microbial Contamination Control Strategy
    • Input Materials
    • Utilities
    • Route of Administration Risk
    • Manufacturing Facilities
    • Manufacturing Process
    • Cell Therapy Product Testing and Release
    • Summary
    • Conclusions
    • Conflict of Interest Declaration
    • Disclaimer
    • Acknowledgments
    • References
  • Figures & Data
  • References
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Contamination Control Strategy: Implementation Road Map
  • Google Scholar

More in this TOC Section

  • Mechanical Container Closure Integrity Test: A Method for Cartridge Systems
  • A Container Closure Integrity Test Method for Vials Stored at Cryogenic Conditions Using Headspace Oxygen Analysis
  • Best Practices for Microbial Challenge In-Use Studies to Evaluate the Microbial Growth Potential of Parenteral Biological Products; Industry and Regulatory Considerations
Show more Technology/Application

Similar Articles

Keywords

  • Risk-based approach
  • Microbial Contamination
  • Cell therapies
  • Donor selection
  • Cell collection
  • Cell transformation and expansion
  • Bacterial endotoxin
  • Sterility
  • Mycoplasma
  • Adventitious viruses
  • Biological safety cabinets
  • Restrictive access barrier systems
  • Isolator systems
  • In-process sterility testing
  • Rapid microbial detection testing

Readers

  • About
  • Table of Content Alerts/Other Alerts
  • Subscriptions
  • Terms of Use
  • Contact Editors

Author/Reviewer Information

  • Author Resources
  • Submit Manuscript
  • Reviewers
  • Contact Editors

Parenteral Drug Association, Inc.

  • About
  • Advertising/Sponsorships
  • Events
  • PDA Bookstore
  • Press Releases

© 2025 PDA Journal of Pharmaceutical Science and Technology Print ISSN: 1079-7440  Digital ISSN: 1948-2124

Powered by HighWire